相似文献
1
spp. as nosocomial pathogens: Epidemiology and resistance features.
Saudi J Biol Sci. 2018 Mar;25(3):586-596. doi: 10.1016/j.sjbs.2016.02.009. Epub 2016 Feb 11.
2
A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids.
Indian J Med Res. 2008 Aug;128(2):178-87.
3
[Epidemiology and clinical features of Acinetobacter baumannii infections in humans].
Berl Munch Tierarztl Wochenschr. 2014 Nov-Dec;127(11-12):447-57.
4
Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
PLoS One. 2021 Nov 15;16(11):e0257272. doi: 10.1371/journal.pone.0257272. eCollection 2021.
5
spp. Infections in Malaysia: A Review of Antimicrobial Resistance Trends, Mechanisms and Epidemiology.
Front Microbiol. 2017 Dec 12;8:2479. doi: 10.3389/fmicb.2017.02479. eCollection 2017.
6
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
7
Nosocomial Acinetobacter pneumonia.
Respirology. 2007 Nov;12(6):787-91. doi: 10.1111/j.1440-1843.2007.01147.x.
8
Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens.
Yonsei Med J. 2011 Nov;52(6):879-91. doi: 10.3349/ymj.2011.52.6.879.
9
Association between antimicrobial resistance among Enterobacteriaceae and burden of environmental bacteria in hospital acquired infections: analysis of clinical studies and national reports.
Heliyon. 2019 Jul 22;5(7):e02054. doi: 10.1016/j.heliyon.2019.e02054. eCollection 2019 Jul.
10
Blue light irradiation triggers the antimicrobial potential of ZnO nanoparticles on drug-resistant Acinetobacter baumannii.
J Photochem Photobiol B. 2018 Mar;180:235-242. doi: 10.1016/j.jphotobiol.2018.02.003. Epub 2018 Feb 6.
引用本文的文献
1
Contamination of hospital surfaces by third-generation cephalosporin-resistant gram-negative bacteria in district hospitals in Mwanza, Tanzania: Urgent need for enhanced infection prevention and control.
Infect Prev Pract. 2025 Jul 5;7(3):100475. doi: 10.1016/j.infpip.2025.100475. eCollection 2025 Sep.
2
Microbial prevalence and understanding of their antimicrobial susceptibility in urinary tract of patients attending at shar teaching hospital (2018-2022).
BMC Res Notes. 2025 Jul 28;18(1):329. doi: 10.1186/s13104-025-07361-6.
3
Distribution of and and the pathogens they are carrying: A systematic review.
Parasite Epidemiol Control. 2025 Jun 4;30:e00437. doi: 10.1016/j.parepi.2025.e00437. eCollection 2025 Aug.
4
Clinical and Epidemiological Aspects on Healthcare-Associated Infections with spp. in a Neurosurgery Hospital in North-East Romania.
Medicina (Kaunas). 2025 May 27;61(6):990. doi: 10.3390/medicina61060990.
5
Molecular Epidemiology and MLST-Based Typing of Pandrug-Resistant Clinical Isolates in Iraq: A Cross-Sectional Study.
Iran J Pathol. 2025 Spring;20(2):173-180. doi: 10.30699/ijp.2025.2052426.3412. Epub 2025 Mar 10.
6
Prevalence and antimicrobial resistance of in the livestock industry in South Korea under a One Health perspective.
One Health. 2025 May 11;20:101071. doi: 10.1016/j.onehlt.2025.101071. eCollection 2025 Jun.
7
The intricacies of : a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications.
Front Microbiol. 2025 May 12;16:1565965. doi: 10.3389/fmicb.2025.1565965. eCollection 2025.
8
Prevalence and Antibiogram Pattern of from 2013 to 2023 in a Tertiary Care Hospital in the Western Region of Saudi Arabia.
Antibiotics (Basel). 2025 Mar 7;14(3):274. doi: 10.3390/antibiotics14030274.
9
The Evolving Landscape of Infective Endocarditis: Difficult-to-Treat Resistance Bacteria and Novel Diagnostics at the Foreground.
J Clin Med. 2025 Mar 19;14(6):2087. doi: 10.3390/jcm14062087.
10
Inhibitory Effect of Antimicrobial Peptides Bac7(17), PAsmr5-17 and PAβN on Bacterial Growth and Biofilm Formation of Multidrug-Resistant .
Microorganisms. 2025 Mar 11;13(3):639. doi: 10.3390/microorganisms13030639.
本文引用的文献
1
Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care.
Open Forum Infect Dis. 2015 Mar 12;2(1):ofv023. doi: 10.1093/ofid/ofv023. eCollection 2015 Jan.
2
Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Acinetobacter baumannii in China.
J Chemother. 2016 Oct;28(5):443-5. doi: 10.1179/1973947815Y.0000000017. Epub 2016 Jul 22.
3
Prevalence of eight resistance-nodulation-division efflux pump genes in epidemiologically characterized Acinetobacter baumannii of worldwide origin.
J Med Microbiol. 2015 Jun;64(6):630-635. doi: 10.1099/jmm.0.000069. Epub 2015 Apr 14.
4
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.
Expert Rev Anti Infect Ther. 2015 Jun;13(6):769-77. doi: 10.1586/14787210.2015.1032254. Epub 2015 Apr 12.
5
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
Int J Antimicrob Agents. 2015 Jun;45(6):568-85. doi: 10.1016/j.ijantimicag.2015.03.001. Epub 2015 Mar 24.
6
Growth phase-specific evolutionary benefits of natural transformation in Acinetobacter baylyi.
ISME J. 2015 Oct;9(10):2221-31. doi: 10.1038/ismej.2015.35. Epub 2015 Apr 7.
7
Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii.
J Bacteriol. 2015 Jun 15;197(12):2027-35. doi: 10.1128/JB.00131-15. Epub 2015 Apr 6.
8
Tetracyclines for multidrug-resistant Acinetobacter baumannii infections.
Int J Antimicrob Agents. 2015 May;45(5):455-60. doi: 10.1016/j.ijantimicag.2014.12.031. Epub 2015 Feb 16.
9
Burden of bacterial meningitis: a retrospective review on laboratory parameters and factors associated with death in meningitis, kelantan malaysia.
Nagoya J Med Sci. 2015 Feb;77(1-2):59-68.
10
Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients.
Int J Antimicrob Agents. 2015 Jun;45(6):670-1. doi: 10.1016/j.ijantimicag.2015.02.005. Epub 2015 Feb 26.
Zotero 插件